VITAL VITAL NSE
Company Profile ↓Company Overview
VITAL (VITAL) is a publicly traded company listed on NSE with a market capitalization of ₹118.20 Cr. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Mar 2026 Revenue of ₹126.44 Cr (-5.6% YoY); net profit ₹1.03 Cr.
- Trailing 12 Months Year-on-year growth — revenue -5.6%, earnings -74.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 2.7%, profit CAGR -49.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 2.70% |
| 1 Year: | -5.57% |
Compounded Profit Growth
| 5 Years: | -49.66% |
| 1 Year: | -74.13% |
Stock Price Performance
| 1 Year: | -8.70% |
| 6 Months: | -6.71% |
| 3 Months: | -17.75% |
| 1 Month: | -1.42% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)47.92 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Earnings shrank at -49.7% CAGR over 5 years.
- Trading 25.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 116.74 Cr | 98.27 Cr | 133.90 Cr | 126.44 Cr |
| Cost of Revenue | - | 88.95 Cr | 81.98 Cr | 105.77 Cr | 97.06 Cr |
| Gross Profit | - | 27.79 Cr | 16.29 Cr | 28.14 Cr | 29.38 Cr |
| Operating Expenses | - | 14.90 Cr | 18.36 Cr | 22.48 Cr | 25.34 Cr |
| Operating Income | - | 12.89 Cr | -2.06 Cr | 5.66 Cr | 4.04 Cr |
| EBITDA | - | 14.37 Cr | 2.96 Cr | 13.14 Cr | 11.20 Cr |
| Interest Expense | - | 57.04 L | 67.84 L | 2.17 Cr | 3.12 Cr |
| Pretax Income | - | 11.48 Cr | -35.26 L | 5.99 Cr | 2.09 Cr |
| Tax Provision | - | 3.43 Cr | 94.97 L | 2.02 Cr | 1.06 Cr |
| Net Income | - | 8.05 Cr | -1.30 Cr | 3.97 Cr | 1.03 Cr |
| Diluted EPS | 3.30 | 4.50 | -0.54 | 1.66 | - |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 137.72 Cr | 137.45 Cr | 181.64 Cr | 218.95 Cr |
| Current Assets | - | 93.02 Cr | 57.98 Cr | 75.06 Cr | 89.94 Cr |
| Cash & Equivalents | - | 30.51 Cr | 48.70 L | 82.13 L | 89.29 L |
| Inventory | - | 13.47 Cr | 12.65 Cr | 13.63 Cr | 31.78 Cr |
| Receivables | - | 38.24 Cr | 39.28 Cr | 46.99 Cr | 39.95 Cr |
| Total Liabilities | - | 48.11 Cr | 53.06 Cr | 88.89 Cr | 119.00 Cr |
| Current Liabilities | - | 25.39 Cr | 36.61 Cr | 47.99 Cr | 72.03 Cr |
| Long Term Debt | - | 22.28 Cr | 16.24 Cr | 40.31 Cr | 43.04 Cr |
| Total Debt | - | 28.80 Cr | 25.78 Cr | 48.14 Cr | 61.87 Cr |
| Total Equity | - | 89.61 Cr | 84.34 Cr | 92.14 Cr | 99.35 Cr |
| Shares Outstanding | - | 2.40 Cr | 2.40 Cr | 2.40 Cr | 2.40 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -8.30 Cr | 13.97 Cr | 5.92 Cr | 4.92 Cr |
| Investing Cash Flow | - | -25.72 Cr | -35.44 Cr | -39.07 Cr | -5.43 Cr |
| Financing Cash Flow | - | 58.29 Cr | -8.56 Cr | 33.49 Cr | 58.11 L |
| Capital Expenditure | - | -9.52 Cr | -20.80 Cr | -45.78 Cr | -23.52 Cr |
| Free Cash Flow | - | -17.82 Cr | -6.82 Cr | -39.86 Cr | -18.61 Cr |
| Net Change in Cash | - | 24.27 Cr | -30.03 Cr | 33.95 L | 7.16 L |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 23.8% | 16.6% | 21.0% | 23.2% |
| Operating Margin % | - | 11.0% | -2.1% | 4.2% | 3.2% |
| Net Margin % | - | 6.9% | -1.3% | 3.0% | 0.8% |
| ROE % | - | 9.0% | -1.5% | 4.3% | 1.0% |
| ROCE % | - | 11.5% | -2.0% | 4.2% | 2.8% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for VITAL
Why Vital Farms (VITL) Stock Is Up Today - stockstory.org
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxOZHpDQUtoVkNkTWptX2NIcHhXRElUUUtzOGxDcjVrd0lVREphQi1QY0RlNVJxTFNmNzA2Y2w1TVhFb3VUSlFHZFpoQ1lkTFVQcEEzRmtIcEpUWGZaMkVmVS1yWXJaWWt1MjNEQlU4R1JhdWxEcEs1V0d3U1UwMzZRZENsUnY2S0NPWGFUdV…
Stock Markets May Be Tired of Iran but a Hormuz Deal Is Vital - Barron's
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxObDBKaHdraWxZTEhuVGttVU1WbjkzM19OUmhEelVFcVVjUUJNQVo1a1J6V2hGMWthZ3RzM3JGc2hzalRUam9pNEtheGwxd08xSVdVMnBsMzdYUXZvVlN6X19fQUZweVJHSzlYb1doU1RDS0Y2eS1jVEhNQ21Bc09MTw?oc=5" target="_…
Vital Farms (VITL) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOa0QwajBxY2lNSk14ZFJnVHF0cllJbTNyWkZkM1ZWX1ZiWWE0MTZxaXZWZlEzZGNhU3BoS3hBSTZ1dTJkbG9fNmlPMDZTdXJRZFM5UnFzYmhGemV5aXdHd2NtcWxnZlpsaWUwRDFCZVk4Z2hjRUxVZ2I1emhtQ016c1NvSUR3dDFDczBvUU…
William Blair cuts Vital Farms stock rating on weak Q1, egg oversupply - Investing.com
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxOc2ZvX1NjNzVqT3E5SGJWSFVMbHJDZHZfdUMwdkFLdm1lLXc3Z192UmgwSG9pXzN5N1FxS19jNVU4S213dlVPODN4QVcyeDlMRDdkZm8zR25Cc3lCZFhDNDZoUjNHODFyTXJQeV9mM3RyQnAxZWdvR294ZE5lRG9OaTVHRVd0eGpFQ3hTdl…
Vital Farms (NASDAQ:VITL) Rating Increased to Buy at Benchmark - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOVDk2WVpnd3E5NFMwS1k1LXdTbEtwNGNYdE4zQ3QzQ1RJVEZCZ01idVFRdm5zVHRGT2lFMmpESU0zek5aOFVJTVUyVnk5WVI2TVM5SlVnblB3ZEh5Z3FnaUFieDlONXkxNFZCN3dyV3ZzY3dleVQyQ0JFTG9ucDdmUnN5d3JXeGllSVVDUH…
Egg oversupply drives Vital Farms to a $31.1M Q2 loss - stocktitan.net
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQb1ppUnBFM2J2a0c5a3B4UzBjR3FUbUpEX05KX1BabTd0SFRzSExzVVFWM25nSjBpbWtBQy1CUENCdjBnT21WaHhueUZuYWQyM1JEekhPLWR4QjRCVzhoNVY5SVM4ZEEwQXd1b21qZGFFT1FmYkNvLVdGRkwxQS1EY09XZ0RRb2NrZHdzVW…
VITAL — Frequently Asked Questions
What is the current share price of VITAL?
As of 2026-08-07 06:31 IST, VITAL trades at ₹49.35 on NSE. Its 52-week range is ₹35.40 to ₹66.15.
What is the market capitalisation of VITAL?
VITAL has a market capitalisation of ₹118.20 Cr on NSE.
What is the P/E ratio of VITAL?
VITAL trades at a trailing price-to-earnings (P/E) ratio of 29.73. Its price-to-book (P/B) ratio is 1.19.
What is the return on equity (ROE) of VITAL?
VITAL has a return on equity (ROE) of 1.03%. Its return on capital employed (ROCE) is 2.75%.
Is VITAL a good stock to buy?
This page provides a data-driven analysis of VITAL, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.